We are live on
!
Find out more
Calamos Advisors Portfolio holdings
AUM
$28.2B
1-Year Est. Return
21.78%
This Fund
S&P 500
This Quarter
Est. Return
+0.71%
1 Year Est. Return
+21.78%
3 Year Est. Return
+69.57%
5 Year Est. Return
+92%
10 Year Est. Return
+282.63%
AUM
$22.9B
AUM Growth
+$1.01B
(+4.6%)
Cap. Flow
-$5.41B
Cap. Flow
% of AUM
-23.63%
Top 10 Holdings %
Top 10 Hldgs %
20.65%
Holding
1,090
New
128
Increased
343
Reduced
93
Closed
104
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$41.8M |
| 2 |
Apple
AAPL
|
+$35.4M |
| 3 |
Amazon
AMZN
|
+$34.6M |
| 4 |
AESC
The AES Corporation
AESC
|
+$30.3M |
| 5 |
Adobe
ADBE
|
+$25.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$236M |
| 2 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$31.2M |
| 3 |
DCUE
Dominion Energy, Inc. 2019 Series A Corporate Units
DCUE
|
+$25M |
| 4 |
Applied Materials
AMAT
|
+$22.1M |
| 5 |
Baxter International
BAX
|
+$20.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.1% |
| 2 | Financials | 8.11% |
| 3 | Healthcare | 7.32% |
| 4 | Consumer Discretionary | 6.91% |
| 5 | Communication Services | 6.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
201
Allstate
ALL
$67.3B
| $14.8M | 0.06% |
116,167
+10,242
| +10% | +$1.35M |
|
202
Northern Trust
NTRS
$22.4B
| $14.8M | 0.06% |
136,854
+8,171
| +6% | +$928K |
|
203
Lockheed Martin
LMT
$134B
| $14.6M | 0.06% |
42,414
+3,743
| +10% | +$1.35M |
|
204
SiTime
SITM
$15.7B
| $14.6M | 0.06% |
71,462
-1,631
| -2% | -$291K |
|
205
Southern Company
SO
$109B
| $14.4M | 0.06% |
233,163
+20,539
| +10% | +$1.32M |
|
206
Celanese
CE
$4.87B
| $14.4M | 0.06% |
95,615
-11,490
| -11% | -$1.77M |
|
207
LPL Financial
LPLA
$26.5B
| $14.4M | 0.06% |
91,818
+16,015
| +21% | +$2.3M |
|
|
PCGU
208
DELISTED
PG&E Corporation
PCGU
| $14.3M | 0.06% |
150,000
| – | – |
|
209
Sherwin-Williams
SHW
$80.7B
| $14.3M | 0.06% |
51,189
+4,516
| +10% | +$1.32M |
|
210
HCA Healthcare
HCA
$86.4B
| $14.3M | 0.06% |
58,922
+5,200
| +10% | +$1.27M |
|
211
Ball Corp
BALL
$17.2B
| $14.2M | 0.06% |
158,295
+14,750
| +10% | +$1.31M |
|
212
CALL
Fidelity National Information Services
FIS
$22.3B
| $14.1M | 0.06% |
+116,000
| New | +$15.6M |
|
213
Ford
F
$58.5B
| $14M | 0.06% |
988,893
-401,526
| -29% | -$5.46M |
|
214
Alibaba
BABA
$276B
| $14M | 0.06% |
94,301
+5,779
| +7% | +$1.05M |
|
215
Kimberly-Clark
KMB
$37B
| $13.9M | 0.06% |
105,081
+9,272
| +10% | +$1.26M |
|
216
Kinder Morgan
KMI
$70.6B
| $13.9M | 0.06% |
831,489
+52,815
| +7% | +$897K |
|
217
Zoetis
ZTS
$32.2B
| $13.9M | 0.06% |
71,558
+6,302
| +10% | +$1.27M |
|
218
Prologis
PLD
$137B
| $13.9M | 0.06% |
110,570
+9,756
| +10% | +$1.27M |
|
219
Johnson Controls International
JCI
$87.5B
| $13.8M | 0.06% |
203,216
+17,932
| +10% | +$1.3M |
|
220
PUT
iShares MSCI Emerging Markets ETF
EEM
$28.6B
| $13.8M | 0.06% |
273,900
-189,100
| -41% | -$9.84M |
|
221
Verisk Analytics
VRSK
$27.1B
| $13.8M | 0.06% |
68,904
+6,080
| +10% | +$1.18M |
|
222
CALL
State Street Financial Select Sector SPDR ETF
XLF
$56.7B
| $13.5M | 0.06% |
+360,000
| New | +$13.5M |
|
223
PUT
Upstart Holdings
UPST
$2.63B
| $13.4M | 0.06% |
+42,500
| New | +$8.38M |
|
224
American Electric Power
AEP
$72.7B
| $13.4M | 0.06% |
164,705
+14,533
| +10% | +$1.27M |
|
225
Eaton
ETN
$155B
| $13.3M | 0.06% |
89,055
+7,858
| +10% | +$1.26M |
|
Similar funds
PCH
N
TWC
FDCDDQ
NA
Calamos Advisors's Q3 2021 Portfolio in Review
As of Q3 2021, Calamos Advisors held 1,090 positions worth $22.9B, up 4.6% from $21.9B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Calamos Advisors withdrew a net $5.41B in Q3 2021, closing 104 positions and reducing 93 holdings. Its most notable exit was Alexion Pharmaceuticals, an estimated $31.2M position sold in full.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 15% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Calamos Advisors opened a new position in AstraZeneca worth $17.8M.
- Calamos Advisors's largest Q3 2021 buy was AstraZeneca: 148,454 shares worth $17.8M.
- Calamos Advisors added most to Microsoft in Q3 2021, an estimated $41.8M increase.
- Calamos Advisors's biggest Q3 2021 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $236M.
- Calamos Advisors fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $31.2M.
- Calamos Advisors's ten largest holdings make up 21% of its $22.9B portfolio in Q3 2021.
- Calamos Advisors opened 128 new positions and closed 104 in Q3 2021.
- Calamos Advisors's portfolio value rose 4.6% quarter-over-quarter to $22.9B.
Based on Calamos Advisors's 13F filing for Q3 2021, filed 26 Oct 2021.